跳到主要导航
跳到搜索
跳到主要内容
Pure University (For Demo Only) 主页
帮助和常见问题
English
中文
0
更多
主页
简介
研究单位
科研成果
设备
数据集
活动
奖项
影响
项目
新闻 / 媒体
按专业知识、名称或附属进行搜索
The Role of ACE-Inhibitors and ARBs in reducing hypertrophic scarring following bilateral breast reduction
Todd Dow, Tamara Selman, Jason Williams,
Michael Bezuhly
Social Sciences
科研成果
:
期刊稿件
›
快报
›
同行评审
2
引用 (Scopus)
0
更多
综述
指纹
指纹
探究 'The Role of ACE-Inhibitors and ARBs in reducing hypertrophic scarring following bilateral breast reduction' 的科研主题。它们共同构成独一无二的指纹。
分类
加权
按字母排序
Keyphrases
Angiotensin Receptor Blockers
100%
ACE Inhibitors
100%
Hypertrophic Scarring
100%
Bilateral Breast Reconstruction
100%
Angiotensin-converting Enzyme Inhibitor (ACEi)
75%
Hypertension
25%
Breast Reconstruction
25%
Reduction Mammoplasty
25%
Timing of Surgery
12%
Inclusion Criteria
12%
Total Population
12%
Operative
12%
Retrospective Chart Review
12%
Clinical Diagnosis
12%
Scar
12%
Angiotensin II (Ang II)
12%
Renin-angiotensin System
12%
Angiotensin II Type 1 Receptor (AT1R)
12%
Hypertension Diagnosis
12%
Patient Charts
12%
Possible Complications
12%
Tissue Fibrosis
12%
Transforming Growth factor-β1 (TGF-β1)
12%
Nursing and Health Professions
Angiotensin Receptor Antagonist
100%
Dipeptidyl Carboxypeptidase Inhibitor
100%
Breast Reduction
100%
Scar Formation
100%
Angiotensin
11%
Renin
11%
Fibrosis
11%
Transforming Growth Factor Beta1
11%
Angiotensin 1 Receptor
11%
Angiotensin II
11%
Medicine and Dentistry
ACE Inhibitor
100%
Angiotensin Receptor Antagonist
100%
Breast Reduction
100%
Scar Formation
100%
Fibrosis
11%
Angiotensin II
11%
Renin Angiotensin Aldosterone System
11%
Transforming Growth Factor Beta1
11%
Angiotensin 1 Receptor
11%
Pharmacology, Toxicology and Pharmaceutical Science
Dipeptidyl Carboxypeptidase Inhibitor
100%
Angiotensin Receptor Antagonist
100%
Scar Formation
100%
Fibrosis
11%
Angiotensin
11%
Renin
11%
Angiotensin II
11%
Angiotensin 1 Receptor
11%
Transforming Growth Factor Beta1
11%